Astra to Market New Heart Drug
Astra Pharmaceutical Products announced Monday that Toprol XL(TM) brand of metoprolol succinate, the nation's first once-a-day dosage form of metoprolol, is available for prescription in the treatment of hypertension and angina. One of the world's most widely prescribed beta blockers, meto...
Saved in:
Published in | Business Wire p. 1 |
---|---|
Main Authors | , , |
Format | Newsletter |
Language | English |
Published |
New York
Business Wire
13.01.1992
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Astra Pharmaceutical Products announced Monday that Toprol XL(TM) brand of metoprolol succinate, the nation's first once-a-day dosage form of metoprolol, is available for prescription in the treatment of hypertension and angina. One of the world's most widely prescribed beta blockers, metoprolol was developed by AB Astra, S dert lje, Sweden. Approximately six million patients worldwide are treated with metoprolol each year. The agent has been available in the U.S. since 1978. Toprol XL , the first new product of Astra's Rx Division, combines the advantages of once-daily dosing with demonstrated beta blockade throughout the entire 24-hour dosing interval. (excerpt) |
---|